Potential Savings in Medicare Part D for Common Urological Conditions

ConclusionsWithin Medicare Part D the potential savings associated with generic substitution for higher cost and nongeneric drugs for 3 common urological conditions surpassed $1 billion, with urologists more likely to prescribe brand-name and more expensive drugs. Increasing low cost and generic drug use where available evidence of efficacy is equivocal represents a promising policy target to optimize prescription drug spending.

Source: Urology Practice - August 25, 2018 Category: Urology & Nephrology Source Type: research